Aura Biosciences, Inc.AURANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank64
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
3.03%
↑ 138% vs avg
Percentile
P64
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-7.93%
Historical baseline
PeriodValue
Q3 20253.03%
Q2 202511.05%
Q1 20252.49%
Q4 2024-56.83%
Q3 20245.30%
Q2 202434.04%
Q1 2024-40.63%
Q4 2023-12.88%
Q3 2023-5.18%
Q2 202310.77%
Q1 20238.89%
Q4 2022-67.41%
Q3 2022-1.24%
Q2 202230.08%
Q1 2022-25.77%
Q4 2021-39.08%
Q3 2021-33.75%
Q2 2021-26.47%
Q1 2021-36.73%
Q4 202043.18%
Q3 2020-12.76%
Q2 202027.50%
Q1 20200.00%